Innovative Computational Methods for Pharmaceutical Problem Solving a Review Part II: Serious Gaming
Abstract
Serious gaming has begun to take a foothold in pharmaceutical problem-solving. Companies such as Akili's Interactive are seeing success in the form of positive clinical trial results and FDA approval of digital therapeutics. Academic researchers have begun exploring novel uses for serious gaming in the way of protein design and more with promising results. This paper provides a review of such topics in addition to topics of game repurposing- repurposing a game originally intended for entertainment into a serious game-such as Minecraft and America's Army. Reviewing these topics this paper shows the utility of serious gaming as a tool for problem-solving while empathizing its applications in the pharmaceutical industry. Further, serious gaming’s utility in other sectors is briefly discussed before concluding. It is suggested that serious games will be a powerful scientific tool both in terms of educational, training, and therapeutic purposes moving forward.
Document Type
Review
Publication Date
8-2021
Funding Information
We would like to acknowledge the Department of Pharmaceutical Sciences at the University of Kentucky for financial support. The project described was supported in part by the NIH National Center for Advancing Translational Sciences through grant number UL1TR001998.
Repository Citation
Campbell, Heather R. and Lodder, Robert A., "Innovative Computational Methods for Pharmaceutical Problem Solving a Review Part II: Serious Gaming" (2021). Pharmaceutical Sciences Faculty Publications. 170.
https://uknowledge.uky.edu/ps_facpub/170
Included in
Computational Engineering Commons, Computer Sciences Commons, Pharmacy and Pharmaceutical Sciences Commons
Notes/Citation Information
Published in CIC Pharmaceutical Sciences.
© 2021 Authors
The copyright holders have granted the permission for posting the article here.
This article is subject to post-publication peer reviews via CIC Pharmaceutical Sciences and thus may have a revised version with a later publication date.